Biotech

According to the report writers, clusters with a large presence of small startups, mid-tier biotech companies and specialty companies flourished in 2013.

With phase 1 safety studies complete, Sinapis is in the middle of raising a $6 million Series B that will fund an upcoming trial in 30 patients with brain injuries, which will establish dosing for the subsequent Phase 2b efficacy study.

"If you start a biotech company in Montana, the governor and our senators take notice and will help with networking opportunities. If you are awarded an SBIR, the state of Montana will kick in matching funds too."

Funding will support the newly-established Crohn’s Disease Collaborative Research Center

Funding will help establish research capabilities at a Montana Center for Aging Research and Memory Care

"If we do nothing but say, ‘Here’s the problem,’ then the problem will continue to grow."

Even as drug-resistant bacteria pose a growing threat globally, the pipeline of new antibiotics is "virtually dry."

Cook began Bacterin in 1998 and grew it from a small contract research group into a publicly traded company with more than 150 employees and multi-million dollar revenues.

The governor touted the advantages of Montana, and said the plant could represent a $30 million investment, create hundreds of construction jobs and 55 permanent jobs, "the jobs of the future."

I’m starting this blog http://directorsblog.nih.gov/ to highlight new discoveries in biology and medicine that I think are game changers, noteworthy, or just plain cool.